COVID-19 Outpatient Therapeutics - Patient Self-Referral Form
5/18/23: Stanford Health Care will be transitioning to only reviewing requests for remdesivir infusions as treatment for COVID-19. If you are seeking another form of treatment, including Paxlovid oral medication, please consult with your primary care provider, local pharmacy, or county health center.
If you develop COVID-19, please inform your healthcare provider. If you are interested in receiving remdesivir infusion as a form of treatment for COVID-19, please complete the SHC treatment self-referral form below. There are several therapeutics that remain active against these resistant subvariants and could be considered treatment options (Paxlovid, remdesivir, or molnupiravir). Please note, our COVID Outpatient Therapeutics team is only accepting remdesivir infusions requests. If you are interested in other treatment options, please consult with your primary care provider or local county health department to further discuss treatment options for COVID-19 treatment.
Thank you for understanding,
The SHC COVID-19 Outpatient Therapeutics Team
Please complete this form to be screened for outpatient COVID-19 treatment. Refer to the eligibility requirements listed below.
For questions, please call (650)-721-5118 Monday through Friday between 8:00 am PST and 4:30 pm PST. Any calls received after hours will be returned on the next business day.
COVID-19 Outpatient Therapeutics at SHC is considered a telemedicine service and may be billed to you or your insurance. Additionally, COVID-19 infusion treatments are no longer covered by the US Government and you may be liable for the total cost. Our Financial Counseling team can provide a Good Faith Estimate and payment options. They can be reached at 650-498-2900 option 2.